SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Bluejay Diagnostics disclosed Q2 2026 financial results for the quarter ended June 30, 2026, reporting a cash position of $9.6 million at quarter-end (versus $5.2 million at year-end 2025) and $7.7 million net cash from financing activities in H1 2026, along with operational progress on the Symphony IL-6 platform.
View raw filing on EDGAR →This is a clear earnings release disclosing financial results for Q2 2026 and six months ended June 30, 2026. The filing explicitly states "On August 13, 2026, DUKE Robotics Corp. issued a press release providing selected financial information for the three and six months ended June 30, 2026" under Item 2.02 (Results of Operations and Financial Condition), with the press release attached as Exhibit 99.1. The disclosure includes detailed revenue, cost of revenues, operating loss, net loss, and balance sheet information, along with business updates on expanded operations and strategic initiatives.
View raw filing on EDGAR →Item 2.02 discloses quarterly financial results for the period ended July 3, 2026, with a press release attached as Exhibit 99.1. The filing reports Q2 2026 revenue of $66.4 million (up 35.2% YoY), adjusted EBITDA of $8.9 million (up 57.9%), and record backlog of $131.5 million. This is a standard earnings release disclosure, material to investors assessing the registrant's financial performance and operational momentum.
View raw filing on EDGAR →The filing discloses NeuroOne's fiscal Q3 2026 financial results via press release dated August 13, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). The press release reports product revenue of $2.0 million (16% YoY growth), gross margins expanding to 59.9%, and product orders of $2.7 million during the quarter, along with operational highlights including ISO 13485 certification and StereoCED platform development milestones. This is a standard quarterly earnings disclosure material to investors assessing the company's financial performance and operational progress.
View raw filing on EDGAR →SS Innovations International disclosed Q2 and H1 2026 financial results via press release dated August 13, 2026, reporting record quarterly revenue of $13.9 million (up 39.4% year-over-year), along with gross profit, net loss, and operational metrics including SSi Mantra installations and cumulative surgeries.
View raw filing on EDGAR →This is a clear earnings release disclosing Presidio Production Company's second quarter 2026 financial results, including net income of $14.4 million ($0.34 per Class A share), total revenue of $54.0 million, and Adjusted EBITDA of $33.2 million. The press release, dated August 11, 2026 and attached as Exhibit 99.1, is the primary disclosure under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for quarterly earnings announcements.
View raw filing on EDGAR →This is a news release announcing DEFSEC's third quarter fiscal 2026 financial results, including revenue of $2.7M (up 92% YoY), gross margin improvement to 33.1% from 28.2%, and cash position of $5.8M. The release explicitly states it is a summary of Q3 Fiscal 2026 results and references the unaudited condensed consolidated interim financial statements filed on SEDAR+ and EDGAR. This is a discrete earnings announcement, not a periodic financial report itself, and would materially affect a reasonable investor's assessment of the company's financial performance and growth trajectory.
View raw filing on EDGAR →This is a news release dated August 13, 2026, announcing DeFi Technologies' second quarter 2026 financial results. The exhibit discloses revenue of $7.8 million, operating loss of $2.3 million, detailed segment performance (Valour AUM, net inflows, and Stillman Digital revenue), and balance sheet metrics including $135 million in combined cash, treasury, and venture portfolio value. The release includes CEO commentary and a shareholder call announcement, all hallmarks of a quarterly earnings announcement.
View raw filing on EDGAR →CapsoVision issued a press release announcing financial results for the fiscal quarter ended June 30, 2026, including quarterly revenue of $3.6 million (up 10% YoY), gross profit, operating expenses, net loss of $7.5 million, and per-share metrics, along with condensed financial statements.
View raw filing on EDGAR →CorMedix issued a press release on August 13, 2026, announcing Q2 2026 financial results including consolidated revenue of $101.9 million, net income of $26.0 million, and adjusted EBITDA of $58.7 million, along with updated full-year 2026 guidance. The disclosure is a standard quarterly earnings announcement furnished as Exhibit 99.1 under Item 2.02, with detailed financial statements and business highlights.
View raw filing on EDGAR →This is a press release announcing Bullish's second quarter 2026 financial results, disclosing Q2'2026 digital asset sales of $32.6 billion, net loss of $(280.0) million, adjusted revenue of $92.6 million, and adjusted EBITDA of $29.5 million. The document explicitly states "Bullish Reports Second Quarter 2026 Results" and includes detailed financial highlights, business metrics, and refined full-year 2026 guidance. This is a material earnings disclosure that would affect a reasonable investor's assessment of the registrant's financial performance and outlook.
View raw filing on EDGAR →This is a clear earnings release disclosing Creative Realities' financial results for the fiscal 2026 second quarter ended June 30, 2026. The press release, furnished as Exhibit 99.1, reports key metrics including revenue of $21.5 million (up from $13.0 million YoY), gross profit of $8.3 million, Adjusted EBITDA of $2.0 million, and ARR of $20.5 million, along with a net loss of $4.2 million. The disclosure is material as it provides investors with the company's quarterly operating performance and financial condition.
View raw filing on EDGAR →This is a clear earnings release disclosing Rekor Systems' Q2 2026 financial results. The 8-K Item 2.02 explicitly states the company "issued a press release summarizing the Company's financial results for the second quarter ended June 30, 2026," with the press release furnished as Exhibit 99.1. The exhibit contains detailed quarterly revenue ($12.7M), gross margin (56%), Adjusted EBITDA loss ($1.2M), and forward guidance toward profitability in H2 2026, along with condensed consolidated balance sheets and management commentary on operational performance.
View raw filing on EDGAR →This is a clear earnings release for Q2 2026 ended June 30, 2026. The Item 2.02 disclosure announces financial results including net revenues of $36.9 million, net income of $409 thousand ($0.02 per diluted share), and Adjusted EBITDA of $2.1 million. The press release (Exhibit 99.1) is attached and highlights the company's "return to profitability for the first time since the first quarter of 2025," making this material to investors assessing the registrant's financial performance and trajectory.
View raw filing on EDGAR →FitLife Brands issued a press release on August 13, 2026 announcing financial results for the quarter ended June 30, 2026, disclosing total revenue of $26.5 million (up 65% YoY), net income of $2.0 million, and EPS of $0.21 basic and $0.20 diluted.
View raw filing on EDGAR →This is a standard quarterly earnings release for Q2 2026 (quarter ended June 30, 2026) filed under Item 2.02. The press release discloses total revenue of $7.4 million, net loss of $12.1 million ($0.54 per diluted share), and includes detailed financial statements and reconciliations to non-GAAP measures. The filing includes the full press release as Exhibit 99.1 and investor presentation as Exhibit 99.2, which are typical components of an earnings disclosure.
View raw filing on EDGAR →ImmuCell issued a press release on August 13, 2026 announcing unaudited financial results for the quarter ended June 30, 2026. The disclosure includes condensed statements of income, balance sheet data, and cash flow data for the period, with management commentary on revenue growth (11.5%), net income ($1.8 million), and operational performance. This is a standard quarterly earnings release attached as Exhibit 99.1, filed under Item 2.02 (Results of Operations and Financial Condition).
View raw filing on EDGAR →Item 2.02 discloses Laird Superfood's financial results for Q2 2026 via a press release (Exhibit 99.1). The press release reports quarterly revenue of $41.3 million (244% increase YoY), net loss of $1.8 million, and adjusted EBITDA of $3.0 million, along with detailed segment and channel performance metrics. This is a standard earnings release disclosure material to investors assessing the registrant's financial performance and growth trajectory.
View raw filing on EDGAR →This is a clear earnings release for Q2 2026 ended June 30, 2026. The press release (Exhibit 99.1) discloses comprehensive financial results including record revenue of $37.6 million (99% YoY growth), net income of $11.6 million ($0.35 per diluted share), and raised full-year 2026 revenue guidance to exceed $145 million. The disclosure is material to investors as it demonstrates strong operational performance and includes forward-looking guidance adjustments.
View raw filing on EDGAR →BK Technologies Corporation disclosed its financial and operating results for the second quarter ended June 30, 2026, through an amended press release (Exhibit 99.1) and an earnings presentation (Exhibit 99.2) furnished under Items 2.02 and 7.01.
View raw filing on EDGAR →The 8-K discloses second quarter 2026 financial results for 22nd Century Group via Item 2.02, with an earnings release furnished as Exhibit 99.1. The release reports Q2 2026 revenues of $2.9 million (down 29.9% YoY), net loss of $3.3 million, and cash position of $6.1 million, along with operational updates on VLN® product commercialization. This is a standard quarterly earnings disclosure material to investors assessing the company's financial performance and cash runway.
View raw filing on EDGAR →The 8-K discloses AIRO's second quarter 2026 financial results via Item 2.02, with a press release attached as Exhibit 99.1. The filing reports Q2 2026 revenue of $43.2 million (76% YoY growth), gross margin of 64%, operating income of $1.7 million, and net loss of $(2) million, along with full-year 2026 revenue guidance of 15-25% growth. This is a standard quarterly earnings release material to investors.
View raw filing on EDGAR →This is a press release announcing Kolibri Global Energy's Q2 2026 financial results, disclosing record quarterly revenue of $22.5 million (109% increase YoY), net income of $8.5 million (197% increase YoY), and production growth of 46%. The document contains condensed consolidated financial statements, detailed operational metrics, and management commentary on results—all hallmarks of an earnings release. Filed as Exhibit 99.5 to a 6-K on August 13, 2026, it discloses material financial performance that would affect a reasonable investor's assessment of the registrant.
View raw filing on EDGAR →The filing discloses Q2 2026 financial results via press release (Item 2.02), including condensed consolidated balance sheets, statements of operations, and cash flows for the six months ended June 30, 2026. While the filing also contains shareholder vote results (Item 5.07), the primary substantive disclosure is the earnings announcement with detailed financial statements showing a net loss of $4.3 million for the six months and cash position of $11.6 million as of June 30, 2026.
View raw filing on EDGAR →The 8-K discloses Abeona Therapeutics' financial results for Q2 2026 under Item 2.02 (Results of Operations and Financial Condition). The press release reports net ZEVASKYN revenue of $11.4 million (31% quarter-over-quarter growth), net loss of $(20.2) million, and cash position of $146.8 million as of June 30, 2026, along with condensed consolidated financial statements. This is a standard quarterly earnings disclosure material to investors assessing the company's commercial progress and financial condition.
View raw filing on EDGAR →The 8-K discloses second-quarter 2026 and half-year financial and operating results via a press release dated August 13, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). The press release includes condensed consolidated balance sheets, statements of operations, and detailed financial highlights showing total assets increased 38% to $511.8 million and total revenue increased 7% year-over-year to $8.5 million for the six-month period. This is a standard earnings release disclosure material to investors.
View raw filing on EDGAR →This is a press release announcing unaudited financial results for the six months ended March 31, 2026. The exhibit discloses revenue of $5.93 million (13.9% growth), gross profit of $1.76 million (20.9% growth), and a net loss of $1.90 million (versus prior-year net income of $0.91 million), along with complete condensed consolidated financial statements. The shift from profitability to loss, driven by significant game enhancement costs ($2.13 million) and professional service fees, is material to investor assessment of the company's financial performance and trajectory.
View raw filing on EDGAR →The 8-K discloses Pulmatrix's second quarter 2026 financial results via a press release dated August 13, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). The press release includes consolidated balance sheets and statements of operations for the periods ended June 30, 2026, along with a corporate update regarding the pending merger with Eos SENOLYTIX. While the filing also discusses M&A activity, the primary disclosure mechanism and Item cited is the earnings release itself, making this the most salient event.
View raw filing on EDGAR →The 8-K discloses financial results for Q2 2026 (ended June 30, 2026) via a press release attached as Exhibit 99.1, filed under Item 2.02 (Results of Operations and Financial Condition). The press release reports $1.5 million in revenue, 2,770 tests processed, a net loss of $14.7 million, and cash position of $33.4 million, along with business highlights including a new laboratory benefit manager coverage policy. This is a standard quarterly earnings release disclosure.
View raw filing on EDGAR →The 8-K discloses financial results for Q2 and six months ended June 30, 2026 via Item 2.02 (Results of Operations and Financial Condition). The press release (Exhibit 99.1) reports revenues of $321,000 (Q2) and $554,000 (six months), net losses of $2.0 million (Q2) and $4.0 million (six months), and includes detailed consolidated balance sheets and statements of operations. This is a standard earnings release disclosure with full financial statements attached.
View raw filing on EDGAR →The 8-K discloses Cingulate's financial results for Q2 2026 (quarter ended June 30, 2026) via Item 2.02 and an attached press release (Exhibit 99.1). The press release reports Q2 and H1 2026 financial results including cash position ($28.4M), R&D expenses ($1.5M for Q2), SG&A expenses ($3.9M for Q2), and net loss ($5.9M for Q2), along with a business update on CTx-1301 regulatory progress and commercial readiness. This is a standard earnings release disclosure material to investors assessing the company's financial condition and operational progress.
View raw filing on EDGAR →The 8-K discloses Co-Diagnostics' financial results for Q2 2026 (quarter ended June 30, 2026) via a press release dated August 13, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). The press release presents revenue ($0.17M), operating loss ($6.2M), net loss ($6.3M or $1.46 per share), and adjusted EBITDA loss ($5.8M), along with business highlights and recent developments. This is a standard quarterly earnings disclosure material to investors assessing the company's financial performance and operational progress.
View raw filing on EDGAR →The filing discloses Q2 2026 financial results via Item 2.02 and an attached press release (Exhibit 99.1). The press release announces quarterly revenue of $2.6 million (up 57% YoY), net loss of $4.0 million (narrowed from Q1), and Adjusted EBITDA loss of $2.6 million. This is a standard earnings release for a public company's quarterly results, material to investors assessing operational performance.
View raw filing on EDGAR →The 8-K discloses Item 2.02 (Results of Operations and Financial Condition) with a press release dated August 13, 2026 reporting record Q2 2026 revenue of approximately $4.5 million and providing forward guidance for Q4 revenue of $6-7 million. The press release highlights major customer wins, production scaling, and margin expansion expectations, which are material to investors assessing the company's financial trajectory and operational performance.
View raw filing on EDGAR →The 8-K discloses third quarter fiscal year 2026 financial results for NANO Nuclear Energy Inc. via a press release filed as Exhibit 99.1. Item 8.01 explicitly states the company "issued a press release reporting its third quarter fiscal year 2026 financial results and providing a business update." The press release includes cash position ($580 million), operating activities ($18.7 million used), investing activities ($297.6 million used), and financing activities ($411.5 million provided), along with key operational achievements including NRC acceptance of a Construction Permit Application and the STS acquisition.
View raw filing on EDGAR →NextBoat Inc. disclosed its fiscal second quarter 2026 financial results via press release dated August 13, 2026, filed under Item 7.01 (Regulation FD Disclosure). The filing reports record revenue of $59.1 million (88.4% YoY increase), record units transacted (138% YoY increase), and gross profit of $9.5 million (100.1% YoY increase), along with condensed consolidated financial statements for the three and six months ended June 30, 2026. This is a standard quarterly earnings release material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →The 8-K discloses second quarter 2026 financial results via a press release dated August 12, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). The press release includes consolidated statements of operations and balance sheet data for the three months ended June 30, 2026, showing net loss of $0.4 million and key operational metrics. While the filing also mentions a material business combination agreement with Future NRG and a securities purchase agreement, the primary disclosure vehicle and Item designation center on the earnings release itself.
View raw filing on EDGAR →Liberty Global disclosed the financial report of its wholly-owned subsidiary VodafoneZiggo for Q2 2026 (quarter ended June 30, 2026) made available on August 13, 2026. Although filed under Item 7.01 (Regulation FD Disclosure) rather than Item 2.02, the substance is a quarterly earnings release for a material operating subsidiary. The disclosure of quarterly financial results for a significant subsidiary would affect a reasonable investor's assessment of the parent company's financial condition and performance.
View raw filing on EDGAR →This is a standard quarterly earnings release for Q2 2026 filed under Item 2.02. The press release (Exhibit 99.1) discloses financial results including R&D expense ($6.8M), G&A expense ($3.6M), net loss ($8.2M), net loss per share ($0.43), and cash position ($23.5M as of June 30, 2026), along with corporate updates on clinical trials and financing activities. The disclosure is material as it provides investors with the company's financial performance and operational progress for the quarter.
View raw filing on EDGAR →This is a straightforward quarterly earnings release for Q2 2026 (three and six months ended June 30, 2026). The press release discloses net sales of $17.8 million (11% increase YoY), gross profit of $3.2 million (30% increase YoY), net loss of $1.2 million (improved from $1.5 million loss in prior year), and cash position of $24.8 million. The filing includes full financial statements and forward guidance for 2026. This is a material disclosure affecting investor assessment of the company's financial performance and operational trajectory.
View raw filing on EDGAR →This is a clear earnings release for Q2 2026 (quarter ended July 4, 2026) filed under Item 2.02 Results of Operations and Financial Condition. The 8-K incorporates by reference a press release (Exhibit 99.1) announcing second quarter financial results including revenue of $506.4 million, diluted EPS of $0.37, and an updated full-year 2026 outlook with raised guidance. The disclosure includes detailed financial statements, segment performance, and management commentary from CEO Chris Hufnagel.
View raw filing on EDGAR →Alliance Laundry issued a press release on August 13, 2026 disclosing second quarter 2026 financial results, including net revenue of $477 million (up 7%), net income of $69 million (up 121%), and Adjusted EBITDA of $134 million (up 12%), along with updated full-year 2026 guidance raising Adjusted EBITDA growth to +8% to 10%. This is a standard quarterly earnings release attached as Exhibit 99.1 to Item 2.02, which is material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →Stratasys disclosed Q2 2026 financial results via press release and earnings presentation, reporting revenue of $137.6 million, GAAP net loss of $16.9 million, and non-GAAP net income of $2.3 million, along with updated full-year 2026 guidance of $565–$575 million in revenue.
View raw filing on EDGAR →ADI Global Distribution Inc. announced second quarter 2026 financial results, reporting record net revenue of $1,286 million, net income of $6 million, and Adjusted EBITDA of $86 million, along with full-year 2026 guidance.
View raw filing on EDGAR →Advanced Flower Capital Inc. issued a press release on August 13, 2026, announcing its financial and operational results for the quarter ended June 30, 2026. The disclosure includes quarterly GAAP net investment income of $3.5 million ($0.15 per share), NAV per share of $8.25, and detailed operating results, portfolio activity, and liquidity metrics. This is a standard quarterly earnings release furnished under Item 2.02 with the full press release attached as Exhibit 99.1.
View raw filing on EDGAR →The filing discloses Intuitive Machines' financial results for the second quarter ended June 30, 2026, via a press release issued on August 13, 2026. The press release reports record quarterly revenue of $206 million, record backlog of $1.8 billion, and provides full-year 2026 guidance of $900 million to $1 billion in revenue. This is a standard earnings release disclosure under Item 2.02, furnished as Exhibit 99.1.
View raw filing on EDGAR →Madison Square Garden Sports Corp. disclosed its financial results for the fourth quarter and full fiscal year ended June 30, 2026 via press release attached as Exhibit 99.1. The disclosure includes consolidated statements of operations, balance sheet data, and detailed revenue and operating income analysis. This is a standard earnings release under Item 2.02, material to investors assessing the company's financial performance and the impact of the Knicks' NBA Championship win on revenues and operating results.
View raw filing on EDGAR →The filing discloses second quarter 2026 financial results for Ovid Therapeutics, including condensed consolidated statements of operations showing revenue, operating expenses, net loss, and loss per share, along with select balance sheet data as of June 30, 2026. The press release (Exhibit 99.1) explicitly announces "Second Quarter 2026 Financial Results" with detailed financial metrics and comparisons to the prior year period, which is the hallmark of an earnings release under Item 2.02.
View raw filing on EDGAR →Applied Materials announced third quarter 2026 financial results on August 13, 2026, disclosing record revenue of $9.12 billion (up 25% YoY), GAAP EPS of $3.17 (up 43% YoY), and non-GAAP EPS of $3.50 (up 41% YoY). The press release, attached as Exhibit 99.1, is a standard earnings release with detailed financial results, segment performance, business outlook, and forward-looking guidance. This is a classic Item 2.02 earnings disclosure material to investors assessing the company's financial performance and growth trajectory.
View raw filing on EDGAR →York Space Systems issued a press release on August 13, 2026, announcing financial results for the fiscal quarter ended June 30, 2026, disclosing Q2 2026 revenue of $92.5 million (up 10% YoY), gross profit of $22.2 million, and a net loss of $39.3 million. The filing also includes full-year 2026 revenue guidance of $375–$405 million and discusses backlog, contract wins, and strategic acquisitions. This is a standard quarterly earnings release furnished under Item 2.02.
View raw filing on EDGAR →